| Primary |
| Atrial Fibrillation |
42.2% |
| Hypertension |
7.5% |
| Product Used For Unknown Indication |
7.5% |
| Hyperlipidaemia |
5.4% |
| Arrhythmia |
4.8% |
| Atrial Flutter |
4.8% |
| Prophylaxis |
4.1% |
| Depression |
2.7% |
| Hypertensive Nephropathy |
2.7% |
| Ischaemic Cardiomyopathy |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Gastritis |
2.0% |
| Thrombosis |
2.0% |
| Acute Coronary Syndrome |
1.4% |
| Arrhythmia Prophylaxis |
1.4% |
| Cardiac Failure |
1.4% |
| Cardiovascular Event Prophylaxis |
1.4% |
| Hypothyroidism |
1.4% |
| Renal Failure Chronic |
1.4% |
| Renal Hypertension |
1.4% |
|
| Drug Interaction |
13.6% |
| Hyperthyroidism |
11.4% |
| Atrial Fibrillation |
6.8% |
| Cardiovascular Disorder |
6.8% |
| Pulmonary Oedema |
6.8% |
| Renal Failure Acute |
6.8% |
| Therapeutic Agent Toxicity |
6.8% |
| Lower Gastrointestinal Haemorrhage |
4.5% |
| Nonspecific Reaction |
4.5% |
| Tachypnoea |
4.5% |
| Upper Gastrointestinal Haemorrhage |
4.5% |
| Vomiting |
4.5% |
| Abdominal Pain |
2.3% |
| Basal Ganglia Haemorrhage |
2.3% |
| Cerebral Haematoma |
2.3% |
| Condition Aggravated |
2.3% |
| Drug Toxicity |
2.3% |
| Electrocardiogram Qt Prolonged |
2.3% |
| Gastritis |
2.3% |
| Haematemesis |
2.3% |
|
| Secondary |
| Atrial Fibrillation |
15.7% |
| Cardiac Failure |
15.7% |
| Product Used For Unknown Indication |
14.5% |
| Arrhythmia |
12.0% |
| Hypertension |
7.2% |
| Pancreatic Neuroendocrine Tumour |
7.2% |
| Arrhythmia Prophylaxis |
3.6% |
| Prophylaxis |
3.6% |
| Anaemia |
2.4% |
| Aortic Valve Disease |
2.4% |
| Atrial Flutter |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Hyperuricaemia |
2.4% |
| Angina Pectoris |
1.2% |
| Cellulitis |
1.2% |
| Cerebrovascular Accident |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Hyperlipidaemia |
1.2% |
| Renal Colic |
1.2% |
| Respiratory Tract Infection |
1.2% |
|
| Tachypnoea |
17.2% |
| Cardiovascular Disorder |
10.3% |
| Therapeutic Agent Toxicity |
10.3% |
| Abdominal Pain |
6.9% |
| Arthralgia |
6.9% |
| Hyperthyroidism |
6.9% |
| Rectal Haemorrhage |
6.9% |
| Retinopathy |
6.9% |
| Atrial Fibrillation |
3.4% |
| Diarrhoea |
3.4% |
| Hemiparesis |
3.4% |
| Hepatitis Toxic |
3.4% |
| International Normalised Ratio Decreased |
3.4% |
| Interstitial Lung Disease |
3.4% |
| Lower Gastrointestinal Haemorrhage |
3.4% |
| Subdural Haemorrhage |
3.4% |
|
| Concomitant |
| Hypertension |
19.6% |
| Atrial Fibrillation |
13.5% |
| Osteoporosis |
10.8% |
| Arrhythmia |
9.5% |
| Product Used For Unknown Indication |
6.1% |
| Cardiac Disorder |
5.4% |
| Renal Transplant |
5.4% |
| Post Herpetic Neuralgia |
4.7% |
| Drug Use For Unknown Indication |
3.4% |
| Pain |
2.7% |
| Prophylaxis |
2.7% |
| Cerebrovascular Accident |
2.0% |
| Diabetes Mellitus |
2.0% |
| Dyslipidaemia |
2.0% |
| Gastric Disorder |
2.0% |
| Hypercholesterolaemia |
2.0% |
| Hypothyroidism |
2.0% |
| Anticoagulant Therapy |
1.4% |
| Benign Prostatic Hyperplasia |
1.4% |
| Cardiac Failure |
1.4% |
|
| Respiratory Arrest |
9.4% |
| Syncope |
9.4% |
| Weight Decreased |
9.4% |
| Cardiac Arrest |
6.3% |
| Hepatitis Acute |
6.3% |
| Osteonecrosis Of Jaw |
6.3% |
| Renal Failure Acute |
6.3% |
| Respiratory Failure |
6.3% |
| Vomiting |
6.3% |
| Adenocarcinoma Gastric |
3.1% |
| Aortic Stenosis |
3.1% |
| Aptyalism |
3.1% |
| Arrhythmia |
3.1% |
| Chest Pain |
3.1% |
| Colon Cancer |
3.1% |
| Diarrhoea |
3.1% |
| Femur Fracture |
3.1% |
| Gastritis Erosive |
3.1% |
| Haemorrhage Intracranial |
3.1% |
| Heart Valve Incompetence |
3.1% |
|
| Interacting |
| Atrial Fibrillation |
24.4% |
| Drug Use For Unknown Indication |
19.5% |
| Acute Coronary Syndrome |
9.8% |
| Myocardial Ischaemia |
7.3% |
| Cardiac Failure |
4.9% |
| Cardiovascular Event Prophylaxis |
4.9% |
| Hypertension |
4.9% |
| Sepsis |
4.9% |
| Atrial Flutter |
2.4% |
| Cardiac Valve Disease |
2.4% |
| Hyperlipidaemia |
2.4% |
| Hyperuricaemia |
2.4% |
| Hypothyroidism |
2.4% |
| Product Used For Unknown Indication |
2.4% |
| Prophylaxis |
2.4% |
| Respiratory Tract Infection |
2.4% |
|
| Drug Interaction |
44.4% |
| Haematemesis |
11.1% |
| Renal Failure Acute |
11.1% |
| Torsade De Pointes |
11.1% |
| Upper Gastrointestinal Haemorrhage |
11.1% |
| Urinary Tract Infection |
11.1% |
|
